Background
This study was conducted to evaluate the pain-reducing efficacy and safety of morphine and dexamethasone-incorporated cocktail regimen in patients undergoing total knee arthroplasty (TKA).
Methods
This study enrolled 213 patients and randomly assigned them to one of three groups. Group I patients were injected with morphine, dexamethasone, bupivacaine, flurbiprofen axetil, and normal saline. Patients in group II were injected with dexamethasone, bupivacaine, flurbiprofen axetil, and normal saline. Patients in control group were administered bupivacaine, flurbiprofen axetil, and normal saline. To compare the pain-controlling efficiency, the visual analog scale (VAS) score, active and passive range of movement (ROM), rescue analgesia use, and 1-min walking distances were recorded and evaluated. Indicators of inflammation include serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) levels, and white blood cells count (WBC) were tested and compared. The following side effects were monitored: headache, dizziness, nausea, vomiting, wound leakage and wound infection.
Results
Group I patients had the lowest VAS and the highest active and passive ROM. In Group I, the VAS reduced from day one to four, but the ROM increased. Group II patients had a smaller reduction in VAS and a smaller increase in ROM, compared with the patients in control group. Patients in group I required the least rescue analgesia use in the first 48 hours postoperative and demonstrated the best walking abilities on postoperative day 2 and day 4. Indicators of inflammation were similar in all enrolled individuals. Following side effects were not recorded: headache, dizziness, nausea, and vomiting. Wound leakage was observed in four patients in group I (two patients) and group II (two patients). No wound infection symptoms were detected.
Conclusions
Morphine and dexamethasone-incorporated cocktail regimen efficiently reduced postoperative pain in patients undergoing primary TKA.
Trial registration:
Randomized controlled trial ISRCTN25027558, registered retrospectively on 27/02/2022. ( https://www.isrctn.com/ISRCTN25027558 )